| 1 |
Siwakoti P, Rennie C, Huang Y, Li JJ, Tuch BE, Mcclements L, Xu X. Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus. Stem Cell Rev and Rep 2022. [DOI: 10.1007/s12015-022-10482-1] [Reference Citation Analysis]
|
| 2 |
Umar AK, Luckanagul JA, Zothantluanga JH, Sriwidodo S. Complexed Polymer Film-Forming Spray: An Optimal Delivery System for Secretome of Mesenchymal Stem Cell as Diabetic Wound Dressing? Pharmaceuticals 2022;15:867. [DOI: 10.3390/ph15070867] [Reference Citation Analysis]
|
| 3 |
Yap SK, Tan KL, Abd Rahaman NY, Saulol Hamid NF, Ooi DJ, Tor YS, Daniel Looi QH, Stella Tan LK, How CW, Foo JB. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats. Pharmaceutics 2022;14:649. [DOI: 10.3390/pharmaceutics14030649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Hu W, Song X, Yu H, Sun J, Wang H, Zhao Y. Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes. Front Endocrinol 2022;12:682145. [DOI: 10.3389/fendo.2021.682145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Kh S, Haider KH. Stem Cells: A Renewable Source of Pancreatic β-Cells and Future for Diabetes Treatment. Stem Cells 2021. [DOI: 10.1007/978-3-030-77052-5_12] [Reference Citation Analysis]
|
| 6 |
Patni AP, Joseph JP, Macrin D, Devi A. Progress in human embryonic stem cell research and aging. Stem Cells and Aging 2021. [DOI: 10.1016/b978-0-12-820071-1.00003-7] [Reference Citation Analysis]
|
| 7 |
Sie NM, Yam GH, Soh YQ, Lovatt M, Dhaliwal D, Kocaba V, Mehta JS. Regenerative capacity of the corneal transition zone for endothelial cell therapy. Stem Cell Res Ther 2020;11:523. [PMID: 33276809 DOI: 10.1186/s13287-020-02046-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 8 |
Abazari MF, Zare Karizi S, Hajati-Birgani N, Norouzi S, Khazeni Z, Hashemi J, Shafaghi L, Soleimanifar F, Mansour RN, Enderami SE. PHBV nanofibers promotes insulin-producing cells differentiation of human induced pluripotent stem cells. Gene 2021;768:145333. [PMID: 33278553 DOI: 10.1016/j.gene.2020.145333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 9 |
Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 89] [Cited by in F6Publishing: 99] [Article Influence: 29.7] [Reference Citation Analysis]
|
| 10 |
Kuncorojakti S, Srisuwatanasagul S, Kradangnga K, Sawangmake C. Insulin-Producing Cell Transplantation Platform for Veterinary Practice. Front Vet Sci 2020;7:4. [PMID: 32118053 DOI: 10.3389/fvets.2020.00004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Pathak V, Pathak NM, O'Neill CL, Guduric-Fuchs J, Medina RJ. Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419844521. [PMID: 31105434 DOI: 10.1177/1179551419844521] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 12 |
Rahim F, Arjmand B, Shirbandi K, Payab M, Larijani B. Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. Stem Cell Investig 2018;5:40. [PMID: 30596080 DOI: 10.21037/sci.2018.11.01] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
